Skip to main content
Clinical Trials/NCT01226199
NCT01226199UnknownNot Applicable

The Expression of TLR2 and TLR4 in the Lung of COPD Patients

Seoul National University Bundang Hospital1 site in 1 country60 target enrollmentStarted: October 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Locations
1

Study Overview

Brief Summary

Smoking is the most important risk factor of COPD, but only a fourth of smokers had COPD in their life. There are also healthy smokers without evidence of COPD. Investigators hypothesize that innate immunity may affect this difference between COPD patients and healthy smokers, because TLR4 is the receptor of LPS, which is the one of important substance in cigarette. Investigators will measure TLR2 and TLR4 expression in lung tissue of patients whose lung will be resected. Investigators will compare the level of expression between COPD patients and healthy smokers.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients who will have lung resection for the therapeutic cause.

Exclusion Criteria

  • Patients who do not agree with our study protocol

Investigators

Study Sites (1)

Loading locations...

Similar Trials